ReviewFrontiers in endocrinology2022
HDAC11, an emerging therapeutic target for metabolic disorders.
Huizhen Chen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
29 papers cite it
this papercites it
ReviewFrontiers in endocrinology2022
Huizhen Chen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.